Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation

被引:127
作者
Chapiro, J
Claverol, S
Piette, F
Ma, WB
Stroobant, V
Guillaume, B
Gairin, JE
Morel, S
Burlet-Schiltz, O
Monsarrat, B
Boon, T
Van den Eynde, BJ
机构
[1] UCL 7459, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium
[2] Univ Catholique Louvain, Cellular Genet Unit, B-1200 Brussels, Belgium
[3] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France
关键词
D O I
10.4049/jimmunol.176.2.1053
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The immunoproteasome (IP) is usually viewed as favoring the production of antigenic peptides presented by MHC class I molecules, mainly because of its higher cleavage activity after hydrophobic residues, referred to as the chymotrypsin-like activity. However, some peptides have been found to be better produced by the standard proteasome. The mechanism of this differential processing has not been described. By studying the processing of three tumor antigenic peptides of clinical interest, we demonstrate that their differential processing mainly results from differences in the efficiency of internal cleavages by the two proteasome types. Peptide gp100(209-217) (ITDQVPSFV) and peptide tyrosinase(369-377) (YMDGTMSQV) are destroyed by the IP, which cleaves after an internal hydrophobic residue. Conversely, peptide MAGE-C2(336-344) (ALKDVEERV) is destroyed by the standard proteasome by internal cleavage after an acidic residue, in line with its higher postacidic activity. These results indicate that the IP may destroy some antigenic peptides due to its higher chymotrypsin-like activity, rather than favor their production. They also suggest that the sets of peptides produced by the two proteasome types differ more than expected. Considering that mature dendritic cells mainly contain IPs, our results have implications for the design of immunotherapy strategies.
引用
收藏
页码:1053 / 1061
页数:9
相关论文
共 53 条
[1]
PROTEASOME SUBUNITS ENCODED IN THE MHC ARE NOT GENERALLY REQUIRED FOR THE PROCESSING OF PEPTIDES BOUND BY MHC CLASS-I MOLECULES [J].
ARNOLD, D ;
DRISCOLL, J ;
ANDROLEWICZ, M ;
HUGHES, E ;
CRESSWELL, P ;
SPIES, T .
NATURE, 1992, 360 (6400) :171-174
[2]
Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus [J].
Basler, M ;
Youhnovski, N ;
van den Broek, M ;
Przybylski, M ;
Groettrup, M .
JOURNAL OF IMMUNOLOGY, 2004, 173 (06) :3925-3934
[3]
INTERFERON-GAMMA STIMULATION MODULATES THE PROTEOLYTIC ACTIVITY AND CLEAVAGE SITE PREFERENCE OF 20S MOUSE PROTEASOMES [J].
BOES, B ;
HENGEL, H ;
RUPPERT, T ;
MULTHAUP, G ;
KOSZINOWSKI, UH ;
KLOETZEL, PM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :901-909
[4]
BURLETSCHILTZ O, IN PRESS METHODS ENZ
[5]
Butz EA, 1998, J IMMUNOL, V160, P2139
[6]
Altered properties of the branched chain amino acid-preferring activity contribute to increased cleavages after branched chain residues by the "immunoproteasome" [J].
Cardozo, C ;
Kohanski, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) :16764-16770
[7]
26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide [J].
Cascio, P ;
Hilton, C ;
Kisselev, AF ;
Rock, KL ;
Goldberg, AL .
EMBO JOURNAL, 2001, 20 (10) :2357-2366
[8]
Immunoproteasomes shape immunodominance hierarchies of antiviral CD8+ T cells at the levels of T cell repertoire and presentation of viral antigens [J].
Chen, WS ;
Norbury, CC ;
Cho, YJ ;
Yewdell, JW ;
Bennink, JR .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :1319-1326
[9]
Mapping and structural dissection of human 20 S proteasome using proteomic approaches [J].
Claverol, S ;
Burlet-Schiltz, O ;
Girbal-Neuhauser, E ;
Gairin, JE ;
Monsarrat, B .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (08) :567-578
[10]
Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide [J].
Craiu, A ;
Akoplan, T ;
Goldberg, A ;
Rock, KL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10850-10855